about
Differential effects of Notch ligands Delta-1 and Jagged-1 in human lymphoid differentiationThe MLL recombinome of acute leukemias in 2013.Significantly improved PCR-based clonality testing in B-cell malignancies by use of multiple immunoglobulin gene targets. Report of the BIOMED-2 Concerted Action BHM4-CT98-3936.EuroClonality/BIOMED-2 guidelines for interpretation and reporting of Ig/TCR clonality testing in suspected lymphoproliferations.The MLL recombinome of acute leukemias in 2017.Targeting CK2 overexpression and hyperactivation as a novel therapeutic tool in chronic lymphocytic leukemia.Polymerase chain reaction (PCR)- and reverse transcription PCR-based minimal residual disease detection in long-term follow-up of childhood acute lymphoblastic leukaemia.Monocarboxylate transporter 1 (MCT1), a tool to stratify acute myeloid leukemia (AML) patients and a vehicle to kill cancer cells.Effects of Delta1 and Jagged1 on early human hematopoiesis: correlation with expression of notch signaling-related genes in CD34+ cells.On CK2 regulation of chronic lymphocytic leukemia cell viability.Heterogeneity of VH–JH gene rearrangement patterns: an insight into the biology of B cell precursor ALLImmunoglobulin heavy-chain gene rearrangement in adult acute lymphoblastic leukemia reveals preferential usage of J(H)-proximal variable gene segmentsMinimal residual disease tests provide an independent predictor of clinical outcome in adult acute lymphoblastic leukemiaImproved reliability of lymphoma diagnostics via PCR-based clonality testing: report of the BIOMED-2 Concerted Action BHM4-CT98-3936
P50
Q24291744-7E0B75A8-9F8A-4A58-B8E3-0D3D6006D928Q34651113-424B0465-4BBC-478D-812D-409630788CCBQ36684897-8820CAA7-F351-4C94-B64C-00F8FBAD99D3Q38037290-8DD2E9EA-3C50-48BA-9B25-FBCFAC66F5C5Q38681972-8D9753A6-9E13-4FD6-99B7-8AC1FD7D6CF9Q39853447-23481BCC-AE31-46A4-9DE8-B7AE138FF9C8Q40621159-0A8DF6CE-2FFB-47BB-9F52-7231A2C153D7Q47111427-8191D820-9620-47A7-85F0-7E17594E6C6DQ51288482-54B611EA-2A2D-416D-8E90-20B9ADAFB3E9Q54574752-43BEB697-3150-4ACE-BF8B-8648C8297B15Q58481907-FF432C35-8816-4AE2-96DA-4604F12E5C5CQ73784993-72876263-0DB1-4CDE-9F15-F74F301FA08AQ77639648-13947D28-3C9D-4B46-9CF3-65398E9172A6Q79434785-7F72237C-94A9-4812-AD5F-5EECBFB43129
P50
description
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
P Gameiro
@ast
P Gameiro
@en
P Gameiro
@es
P Gameiro
@nl
type
label
P Gameiro
@ast
P Gameiro
@en
P Gameiro
@es
P Gameiro
@nl
prefLabel
P Gameiro
@ast
P Gameiro
@en
P Gameiro
@es
P Gameiro
@nl
P106
P1153
55371512100
P31
P496
0000-0002-3761-7050